Guardion Health Sciences, Inc. (GHSI)
USD 3.22
(0.0%)
USD 3.22
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 158.03 Thousand USD | 100.52% |
| 2022 | -30.27 Million USD | -22.36% |
| 2021 | -24.74 Million USD | -188.44% |
| 2020 | -8.57 Million USD | 22.97% |
| 2019 | -11.13 Million USD | -43.38% |
| 2018 | -7.76 Million USD | -46.41% |
| 2017 | -5.3 Million USD | 7.71% |
| 2016 | -5.74 Million USD | 34.98% |
| 2015 | -8.84 Million USD | -569.55% |
| 2014 | -1.32 Million USD | -6.26% |
| 2013 | -1.24 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.93 Million USD | 317.5% |
| 2024 Q1 | -4.74 Million USD | -1217.62% |
| 2023 Q3 | 372.63 Thousand USD | 131.78% |
| 2023 FY | 158.03 Thousand USD | 100.52% |
| 2023 Q1 | 2.53 Million USD | 110.43% |
| 2023 Q2 | -1.17 Million USD | -146.34% |
| 2023 Q4 | 424.72 Thousand USD | 13.98% |
| 2022 Q2 | -1.7 Million USD | 35.56% |
| 2022 Q1 | -2.64 Million USD | 81.81% |
| 2022 FY | -30.27 Million USD | -22.36% |
| 2022 Q4 | -24.24 Million USD | -1329.62% |
| 2022 Q3 | -1.69 Million USD | 0.34% |
| 2021 FY | -24.74 Million USD | -188.44% |
| 2021 Q2 | -4.54 Million USD | -70.08% |
| 2021 Q1 | -2.66 Million USD | 20.88% |
| 2021 Q3 | -3.01 Million USD | 33.6% |
| 2021 Q4 | -14.52 Million USD | -381.63% |
| 2020 Q1 | -2.34 Million USD | 42.13% |
| 2020 Q3 | -2.14 Million USD | -203.11% |
| 2020 Q4 | -3.37 Million USD | -57.41% |
| 2020 FY | -8.57 Million USD | 22.97% |
| 2020 Q2 | -707.16 Thousand USD | 69.87% |
| 2019 Q2 | -3.04 Million USD | -120.08% |
| 2019 Q3 | -2.38 Million USD | 21.75% |
| 2019 Q4 | -4.05 Million USD | -70.03% |
| 2019 FY | -11.13 Million USD | -43.38% |
| 2019 Q1 | -1.38 Million USD | 6.17% |
| 2018 Q4 | -1.47 Million USD | 31.28% |
| 2018 Q3 | -2.14 Million USD | -18.68% |
| 2018 Q2 | -1.81 Million USD | 22.43% |
| 2018 Q1 | -2.33 Million USD | -6.25% |
| 2018 FY | -7.76 Million USD | -46.41% |
| 2017 FY | -5.3 Million USD | 7.71% |
| 2017 Q4 | -2.19 Million USD | -38.61% |
| 2017 Q3 | -1.58 Million USD | -85.16% |
| 2017 Q2 | -855.66 Thousand USD | -27.9% |
| 2017 Q1 | -669.01 Thousand USD | 71.01% |
| 2016 Q1 | -949.2 Thousand USD | 21.08% |
| 2016 FY | -5.74 Million USD | 34.98% |
| 2016 Q4 | -2.3 Million USD | -102.23% |
| 2016 Q3 | -1.14 Million USD | 15.52% |
| 2016 Q2 | -1.35 Million USD | -42.29% |
| 2015 FY | -8.84 Million USD | -569.55% |
| 2015 Q3 | -2.54 Million USD | 0.12% |
| 2015 Q2 | -2.54 Million USD | 0.0% |
| 2015 Q1 | -2.54 Million USD | -629.92% |
| 2015 Q4 | -1.2 Million USD | 52.72% |
| 2014 Q4 | -348.96 Thousand USD | 0.0% |
| 2014 FY | -1.32 Million USD | -6.26% |
| 2013 FY | -1.24 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bright Green Corporation | -13.12 Million USD | 101.204% |
| BioQuest Corp. | -123.33 USD | 128238.328% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | 100.883% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 99.557% |
| GSRX Industries Inc. | - USD | -Infinity% |
| High Sierra Technologies, Inc. | -323.95 Thousand USD | 148.783% |
| Instadose Pharma Corp. | - USD | -Infinity% |